Open access · CC-BY
via OpenAlex
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Samuel A.J. Trammell, Mark S. Schmidt, Benjamin J. Weidemann, Philip Redpath, Frank Jaksch, Ryan W. Dellinger, Zhonggang Li, E. Dale Abel, Marie E. Migaud, Charles Brenner
Nature Communications · 2016 · ▲ 704 citations
Abstract
Abstract Nicotinamide riboside (NR) is in wide use as an NAD + precursor vitamin. Here we determine the time and dose-dependent effects of NR on blood NAD + metabolism in humans. We report that human blood NAD + can rise as much as 2.7-fold with a single oral dose of NR in a pilot study of one individual, and that oral NR elevates mouse hepatic NAD + with distinct and superior pharmacokinetics to those of nicotinic acid and nicotinamide. We further show that single doses of 100, 300 and 1,000 mg of NR produce dose-dependent increases in the blood NAD + metabolome in the first clinical trial of NR pharmacokinetics in humans. We also report that nicotinic acid adenine dinucleotide (NAAD), which was not thought to be en route for the conversion of NR to NAD + , is formed from NR and discover that the rise in NAAD is a highly sensitive biomarker of effective NAD + repletion.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1038/ncomms12948
- Canonical
- link ↗
- Fetched
- 2026-06-16 MST
Cite this
APA
Trammell, S.A., Schmidt, M.S., Weidemann, B.J., Redpath, P., Jaksch, F., Dellinger, R.W., Li, Z., Abel, E.D., Migaud, M.E., & Brenner, C. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. <em>Nature Communications</em>. https://doi.org/10.1038/ncomms12948
Vancouver
Trammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, et al. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications. 2016. doi:10.1038/ncomms12948.
BibTeX
@article{samuel2016Nicoti,
title = {Nicotinamide riboside is uniquely and orally bioavailable in mice and humans},
author = {Samuel A.J. Trammell and Mark S. Schmidt and Benjamin J. Weidemann and Philip Redpath and Frank Jaksch and Ryan W. Dellinger and Zhonggang Li and E. Dale Abel and Marie E. Migaud and Charles Brenner},
journal = {Nature Communications},
year = {2016},
doi = {10.1038/ncomms12948},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
PLoS ONE 2017
Open access · CC-BY
An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers
The FASEB Journal 2021
Open access · OA
Reduced nicotinamide mononucleotide is a new and potent NAD <sup>+</sup> precursor in mammalian cells and mice
npj Aging and Mechanisms of Disease 2017
Open access · CC-BY
Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled study
Metabolites 2019
Open access · CC-BY
Degradation of Extracellular NAD+ Intermediates in Cultures of Human HEK293 Cells
Frontiers in Nutrition 2022
Open access · CC-BY
Oral Administration of Nicotinamide Mononucleotide Is Safe and Efficiently Increases Blood Nicotinamide Adenine Dinucleotide Levels in Healthy Subjects
The Plant Journal 2007
Preprint · OA